[image] Sponsored by: [image]() [MYMD](=) is quietly building a lot of strength in what can only be described as a âweak marketâ. Even Yahoo Finance has it rated as a short-term âbullishâ right now: [image] What I really want to see is the stock hold above the $3 level for at least a couple of days. If it can do that, then I think this has a decent shot of testing the 200-day moving average near $3.70. Personally, I think there is much more potential than that. Just look at the potential benefits of its leading drug candidate, MYMD-1®, especially in regard to current TNF-alpha inhibitors on the market â itâs NO SURPRISE why! TNF inhibitors have been the leading drugs by revenue for years, only falling to Pfizerâs Covid vaccine in the last couple of years. For example, Humira is expected to be SECOND in projected sales of over $20B in 2022. What most people donât know is that all of these top-prescribed TNF inhibitors are in LARGE molecule form, which means they are UNABLE to cross the blood brain barrier â this barrier prevents harmful substances from entering the brain. However, it also keeps out beneficial medications that can treat brain-related disorders, including multiple sclerosis (MS) as well as depression in age or inflammatory-related diseases. This is where MYMD-1® differs â as it is in SMALL molecule form it is being designed to cross the blood brain barrier â opening up all kinds of possibilities in treating brain-related disorders, including potentially MS! [image] Currently, MYMD-1® is in Phase 2 trials for sarcopenia (aging) but the company has near term plans to advance MYMD-1® into a phase 2 clinical trial for rheumatoid arthritis. So keep your eye on this company as it has ambitious plans to tackle some of the biggest health challenges facing our population today! To Your Success! ISSUER-PAID ADVERTISEMENT: MyMD, Inc. (âMYMDâ or the âCompanyâ) HAS PAID OR WILL PAY SHERWOOD VENTURES, LLC (âSherwoodâ) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE âINITIAL TERMâ) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOODâS AFFILIATE RAGINGBULL.COM, LLC (âRAGING BULLâ), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER [( DISCLAIMER: To more fully understand any Ragingbull.com, LLC (âRagingBullâ) subscription, website, application or other service (âServicesâ), please review our full disclaimer located at [(=) FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED.RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial.However, subscribersâ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [Ragingbull.com](=), LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, [Ragingbull.com](), LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. If you have a current active subscription with RagingBull you will need to contact us [here](=) if you want to cancel your subscription. Opting out of emails does not remove you from your service at RagingBull. [Unsubscribe]( RagingBull.com, LLC 62 Calef Hwy #233 Lee, New Hampshire 03861 United States (800) 380-7072